Innate Pharma S.A. ADR (IPHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Sales | 96,112 | 110,957 | 0 | 0 | 0 |
| Gross Profit | 96,112 | 110,957 | N/A | N/A | N/A |
| Operating Expenses | 126,410 | 104,880 | 0 | 0 | 0 |
| Operating Income | -30,298 | 6,077 | N/A | N/A | N/A |
| Interest Expense | 5,573 | 9,955 | 0 | 0 | 0 |
| Other Income | 12,621 | 7,087 | 0 | 0 | 0 |
| Pre-tax Income | -23,250 | 3,210 | 0 | 0 | 0 |
| Income Tax | N/A | -393 | N/A | N/A | N/A |
| Net Income Continuous | -23,250 | 3,601 | N/A | N/A | N/A |
| Net Income | $-23,250 | $3,601 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -0.35 | 0.06 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -0.35 | 0.06 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.35 | 0.06 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -0.35 | 0.06 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -0.34 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-11,786 | $14,818 | $N/A | $N/A | $N/A |